DNA-RNA synthesis inhibitor, Bleomycin, Purity ≥98%

Synonym: 11056-06-7; Bleo; Bleocin; BLM; 3-[[2-[2-[2-[[(2S,3R)-2-[[(2S,3S,4R)-4-[[(2S,3R)-2-[[6-Amino-2-[(1S)-3-amino-1-[[(2S)-2,3-diamino-3-oxopropyl]amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[3-[4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-1,3-thiazol-4-yl]-1,3-thiazole-4-carbonyl]amino]propyl-dimethylsulfanium

CAS Number: 11056-06-7
Compound CID: 5360373

Product Size

5 mg; 10 mg; 25 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Bleomycin is an effective DNA damage inhibitor, that has the ability to prevent the pathway of DNA damage by inhibiting DNA-RNA synthesis.

Molecular Weight

1415.55

Molecular Formula

C₅₅H₈₄N₁₇O₂₁S₃

Form

Lyophilized powder

Purity

≥98%

Titer

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects

Stability

In its lyophilized form, the chemical remains stable for 36 months.

Quality Level

Research grade

Applications

Bleomycin is a DNA damage inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of Hodgkin’s lymphoma, testicular cancer, and certain types of head and neck cancers.

Storage

Store at -20ºC, and keep desiccated.